BioPoly, LLC news

FORT WAYNE, IN – BioPoly LLC has announced that the U.S. Food and Drug Administration has granted clearance for its BioPoly^® Great Toe Implant.  With this FDA clearance, the BioPoly technology is available for the first time in the U.S. 

BioPoly first received regulatory approval in 2012 for its knee implants in Europe. “Although we have been in patients in Europe with our knee implants for nearly 10 years, we are extremely excited to be able to en

FORT WAYNE, IN – BioPoly LLC has announced that the first BioPoly^® Great Toe surgery in the U.S. was completed on September 30, 2021. The surgery was performed by Dr. Steve Herbst of Central Indiana Orthopedics in Muncie, Indiana.

“The BioPoly Great Toe implant addresses a large unmet need in the market, and we are thrilled to have it available in the U.S. now. This small implant has a lot of technology packed into it and solves many of the issues that have

FORT WAYNE, IN – BioPoly LLC has announced that the Company has further expanded its intellectual property portfolio. The Company was granted another international patent for its partial resurfacing implants which protects the innovative implant designs. In addition to patents that cover the design of its implants, several U.S. and international patents have also been granted that address the Company’s unique BioPoly^® material.  The Company’s IP portfolio